HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CG 301269

structure in first source

Also Known As:

CG-301269; CG301269

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - CG 301269: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - Thiazolidines: 105
      - CG 301269: 1

Experts

1.	Choe, Sung Sik: 1 article (02/2011)
2.	Choi, Eun Bok: 1 article (02/2011)
3.	Chung, Heekyoung: 1 article (02/2011)
4.	Jeong, Hyun Woo: 1 article (02/2011)
5.	Kim, Hyo-Soo: 1 article (02/2011)
6.	Kim, Jae Bum: 1 article (02/2011)
7.	Kim, Kyung-Hee: 1 article (02/2011)
8.	Kim, Woo Sik: 1 article (02/2011)
9.	Lee, Gha Young: 1 article (02/2011)
10.	Lee, Hanjae: 1 article (02/2011)

Related Diseases

1.	Obesity 02/01/2011 - "Our data suggest that CG301269 would be a potential lead compound against obesity and related metabolic disorders."
2.	Insulin Resistance 02/01/2011 - "CG301269 enhanced fatty acid oxidation in vitro and ameliorated insulin resistance and hyperlipidemia in vivo. "
3.	Hyperlipidemias (Hyperlipidemia) 02/01/2011 - "CG301269 enhanced fatty acid oxidation in vitro and ameliorated insulin resistance and hyperlipidemia in vivo. "
4.	Fatty Liver 02/01/2011 - "In db/db mice, CG301269 reduced inflammatory responses and fatty liver, without body weight gain. "
5.	Body Weight (Weight, Body) 02/01/2011 - "In db/db mice, CG301269 reduced inflammatory responses and fatty liver, without body weight gain. " 02/01/2011 - "A newly identified CG301269 improves lipid and glucose metabolism without body weight gain through activation of peroxisome proliferator-activated receptor alpha and gamma."

Related Drugs and Biologics

1.	PPAR alpha
2.	Lipids
3.	Glucose (Dextrose)
4.	Fatty Acids (Saturated Fatty Acids)